Farrag et al. discovered that PD-L1 is over-expressed in lung cancer, particularly in NSCLCs, where 71% of positive cases showed high positive expression and 59.1% of positive cases showed low positive expression [14]. The gene discussed is CD274; the disease is lung carcinoma.